GFS Chemicals, Inc. – Trademark Portfolio

Entity Type: 03

GFS Chemicals, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 40 (Treatment & Processing) across 2 Nice Classification classes. Currently, 6 trademarks are registered and 1 is pending. Notable registered marks include GFS, IN-SPEC, VERITAS, WATERMARK, and AMCO CLEAR. The owner is based in Powell, OH.

155 Hidden Ravines Suite A

Powell, OH 43065

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

GFS Chemicals, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (7 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

40
Treatment & Processing (3 filings)

Treatment of materials

Frequently Asked Questions

How many trademarks does GFS Chemicals, Inc. have?

GFS Chemicals, Inc. has 8 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 pending, 1 cancelled.

What trademark classes does GFS Chemicals, Inc. file in?

GFS Chemicals, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are GFS Chemicals, Inc.'s most well-known trademarks?

GFS Chemicals, Inc.'s registered trademark portfolio includes well-known marks such as GFS, IN-SPEC, VERITAS, WATERMARK, and AMCO CLEAR. These are among 6 currently registered trademarks in the portfolio.

What is GFS Chemicals, Inc.'s trademark registration success rate?

GFS Chemicals, Inc. has a 86% trademark registration rate, with 6 out of 7 resolved applications resulting in successful registration. Currently, 1 application is pending review.